The Role of Autophagy in Parkinson's Disease: Rotenone-Based Modeling

Nian Xiong,Jing Xiong,Min Jia,Ling Liu,Xiaowei Zhang,Zhenzhen Chen,Jinsha Huang,Zhentao Zhang,Lingling Hou,Zhijian Luo,Devina Ghoorah,Zhicheng Lin,Tao Wang
DOI: https://doi.org/10.1186/1744-9081-9-13
IF: 5.1
2013-01-01
Behavioral and Brain Functions
Abstract:BACKGROUND:Autophagy-mediated self-digestion of cytoplasmic inclusions may be protective against neurodegenerative diseases such as Parkinson's disease (PD). However, excessive autophagic activation evokes autophagic programmed cell death.METHODS:In this study, we aimed at exploring the role of autophagy in the pathogenesis of rotenone-induced cellular and animal models for PD.RESULTS:Reactive oxygen species over-generation, mitochondrial membrane potential reduction or apoptosis rate elevation occurred in a dose-dependent fashion in rotenone-treated human neuroblastoma cell line SH-SY5Y. The time- and dose-dependent increases in autophagic marker microtubule-associated protein1 light chain 3 (LC3) expression and decreases in autophagic adaptor protein P62 were observed in this cellular model. LC3-positive autophagic vacuoles were colocalized with alpha-synuclein-overexpressed aggregations. Moreover, the number of autophagic vacuoles was increased in rotenone-based PD models in vitro and in vivo.CONCLUSIONS:These data, along with our previous finding showing rotenone-induced toxicity was prevented by the autophagy enhancers and was aggravated by the autophagy inhibitors in SH-SY5Y, suggest that autophagy contributes to the pathogenesis of PD, attenuates the rotenone toxicity and possibly represents a new subcellular target for treating PD.
What problem does this paper attempt to address?